A Stanford Medicine researcher provides insight into how to protect yourself and your home during wildfire season.
With "bubbles" and "spacesuits," Stanford Medicine scientists take on the challenge of researching SARS-CoV-2 in the lab.
Stanford Medicine researchers and others discovered 13 genetic signatures that are closely linked to an increased risk for severe COVID-19.
Two Stanford gynecologists talk about pelvic and sexual pain, and why it's so important to empower patients to address it.
In addressing decades of structural racism in health care, Stanford Medicine researchers are devising new strategies to reach racial equity.
Staff and faculty from across Stanford Medicine are stepping up to vaccinate members of the community at sites across the Bay Area.
Ten years after a Stanford patient suffered a massive stroke and underwent two brain surgeries, she's publishing a book of poems.
Stanford Medicine researchers have found a new way to stabilize mRNA molecules, something that could boost COVID vaccines.
Stanford Medicine researchers and collaborators aiming to predict and detect COVID-19 through smartwatch data expand user base into Pac-12 athletes.
Stanford chaplains help patients, patient families and hospital staff impacted by COVID-19 fulfill their spiritual needs.
Euan Ashley, professor of medicine and genetics, tells the stories of his patients with rare or mystery diseases through his new book, The Genome Odyssey.
In the burgeoning field of pharmacogenetics, adhering to expert-developed guidelines is increasingly important, a Stanford Medicine physician emphasizes.
Researchers at Stanford are using data from a menstrual cycle tracking app to better understand variation in mood, behavior, and other health parameters.
Stanford Medicine researchers found that, based on genetic makeup, 99.5% of people are likely to have an atypical response to at least one drug.
In Stanford Medicine's Recover, Restore and Re-open framework, experts discuss how the shift to telehealth likely represents the new norm.
Doctors and researchers are prioritizing a digital-first approach as they adapt clinical trials to the COVID-19 pandemic.